Spanish Regulator Grants Enlivex Authorization To Expand Its Sepsis Phase II into Spain

NEXT STORY
Akoya Biosciences to Present Data at SITC 2021 Highlighting Novel Spatial Biology Applications
PREV STORY
Global Active Pharmaceutical Ingredients (API) Markets, 2021-2026 – Invention Of New Generation APIs & Growth In API Outsourcing Operations
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TRACON Pharmaceuticals Announces Closing of Previously Announced Private Placement and Appointment of Ted Wang, Ph.D., of Puissance Capital Management, to Board of Directors

author_avatar
NASDAQ Market News

TiGenix Appoints Dr. June Almenoff to its Board of Directors

LEUVEN, Belgium, Sept. 22, 2016 (GLOBE NEWSWIRE) -- TiGenix NV (Euronext Brussels: TIG), an ...

author_avatar
NASDAQ Market News

Tonix Pharmaceuticals Presents at EULAR Results of a Retrospective Analysis from the Phase 2b BESTFIT Clinical Study of TNX-102 SL in Fibromyalgia

NEW YORK, June 09, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), ...

author_avatar
NASDAQ Market News